Logo image of ASRNL.AS

ASR NEDERLAND NV (ASRNL.AS) Stock Fundamental Analysis

AMS:ASRNL - Euronext Amsterdam - NL0011872643 - Common Stock - Currency: EUR

56.24  +0.04 (+0.07%)

Fundamental Rating

3

Taking everything into account, ASRNL scores 3 out of 10 in our fundamental rating. ASRNL was compared to 37 industry peers in the Insurance industry. Both the profitability and financial health of ASRNL have multiple concerns. ASRNL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ASRNL had positive earnings in the past year.
In the past year ASRNL has reported a negative cash flow from operations.
ASRNL had positive earnings in 4 of the past 5 years.
In multiple years ASRNL reported negative operating cash flow during the last 5 years.
ASRNL.AS Yearly Net Income VS EBIT VS OCF VS FCFASRNL.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

ASRNL's Return On Assets of 0.64% is on the low side compared to the rest of the industry. ASRNL is outperformed by 70.27% of its industry peers.
ASRNL has a worse Return On Equity (9.01%) than 67.57% of its industry peers.
ASRNL's Return On Invested Capital of 3.00% is amongst the best of the industry. ASRNL outperforms 83.78% of its industry peers.
Industry RankSector Rank
ROA 0.64%
ROE 9.01%
ROIC 3%
ROA(3y)-0.5%
ROA(5y)0.09%
ROE(3y)-2.82%
ROE(5y)2.67%
ROIC(3y)N/A
ROIC(5y)N/A
ASRNL.AS Yearly ROA, ROE, ROICASRNL.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Profit Margin value of 5.79%, ASRNL is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
ASRNL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 35.94%, ASRNL belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
ASRNL's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.94%
PM (TTM) 5.79%
GM N/A
OM growth 3Y3.92%
OM growth 5Y-0.14%
PM growth 3Y-6.35%
PM growth 5Y-7.93%
GM growth 3YN/A
GM growth 5YN/A
ASRNL.AS Yearly Profit, Operating, Gross MarginsASRNL.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASRNL is destroying value.
The number of shares outstanding for ASRNL has been reduced compared to 1 year ago.
The number of shares outstanding for ASRNL has been increased compared to 5 years ago.
ASRNL has a better debt/assets ratio than last year.
ASRNL.AS Yearly Shares OutstandingASRNL.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ASRNL.AS Yearly Total Debt VS Total AssetsASRNL.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

ASRNL has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ASRNL (1.09) is worse than 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.19
WACC15.92%
ASRNL.AS Yearly LT Debt VS Equity VS FCFASRNL.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ASRNL.AS Yearly Current Assets VS Current LiabilitesASRNL.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ASRNL have decreased strongly by -31.60% in the last year.
Measured over the past years, ASRNL shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.32% on average per year.
The Revenue has grown by 31.67% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 7.88% on average over the past years.
EPS 1Y (TTM)-31.6%
EPS 3Y-12.51%
EPS 5Y-8.32%
EPS Q2Q%28.86%
Revenue 1Y (TTM)31.67%
Revenue growth 3Y6.3%
Revenue growth 5Y7.88%
Sales Q2Q%7.19%

3.2 Future

The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
ASRNL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.00% yearly.
EPS Next Y33.96%
EPS Next 2Y18.93%
EPS Next 3Y17.51%
EPS Next 5Y8.79%
Revenue Next Year4.63%
Revenue Next 2Y4.52%
Revenue Next 3Y7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ASRNL.AS Yearly Revenue VS EstimatesASRNL.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ASRNL.AS Yearly EPS VS EstimatesASRNL.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ASRNL is valuated correctly with a Price/Earnings ratio of 16.44.
ASRNL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.91. ASRNL is valued slightly cheaper when compared to this.
ASRNL is valuated reasonably with a Price/Forward Earnings ratio of 10.73.
ASRNL's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ASRNL to the average of the S&P500 Index (21.77), we can say ASRNL is valued rather cheaply.
Industry RankSector Rank
PE 16.44
Fwd PE 10.73
ASRNL.AS Price Earnings VS Forward Price EarningsASRNL.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASRNL is valued cheaper than 97.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.29
ASRNL.AS Per share dataASRNL.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ASRNL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASRNL's earnings are expected to grow with 17.50% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y18.93%
EPS Next 3Y17.51%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.36%, ASRNL is a good candidate for dividend investing.
ASRNL's Dividend Yield is a higher than the industry average which is at 4.50.
Compared to an average S&P500 Dividend Yield of 2.40, ASRNL pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.36%

5.2 History

The dividend of ASRNL is nicely growing with an annual growth rate of 18.44%!
Dividend Growth(5Y)18.44%
Div Incr Years3
Div Non Decr Years3
ASRNL.AS Yearly Dividends per shareASRNL.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

71.32% of the earnings are spent on dividend by ASRNL. This is not a sustainable payout ratio.
ASRNL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP71.32%
EPS Next 2Y18.93%
EPS Next 3Y17.51%
ASRNL.AS Yearly Income VS Free CF VS DividendASRNL.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B
ASRNL.AS Dividend Payout.ASRNL.AS Dividend Payout, showing the Payout Ratio.ASRNL.AS Dividend Payout.PayoutRetained Earnings

More info and screens

ASR NEDERLAND NV

AMS:ASRNL (5/27/2025, 5:36:15 PM)

56.24

+0.04 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)08-20 2025-08-20
Inst Owners80.9%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap11.89B
Analysts84.35
Price Target57.82 (2.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.36%
Yearly Dividend2.99
Dividend Growth(5Y)18.44%
DP71.32%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.67%
PT rev (3m)4.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE 16.44
Fwd PE 10.73
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 1.29
EV/EBITDA 2.29
EPS(TTM)3.42
EY6.08%
EPS(NY)5.24
Fwd EY9.32%
FCF(TTM)-3.45
FCFYN/A
OCF(TTM)-3.31
OCFYN/A
SpS72.13
BVpS46.31
TBVpS43.51
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 9.01%
ROCE 4.12%
ROIC 3%
ROICexc 3.1%
ROICexgc 3.52%
OM 35.94%
PM (TTM) 5.79%
GM N/A
FCFM N/A
ROA(3y)-0.5%
ROA(5y)0.09%
ROE(3y)-2.82%
ROE(5y)2.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-10.55%
ROICexcg growth 5Y-6.2%
ROICexc growth 3Y-10.91%
ROICexc growth 5Y-6.29%
OM growth 3Y3.92%
OM growth 5Y-0.14%
PM growth 3Y-6.35%
PM growth 5Y-7.93%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA 1.91
Cap/Depr 26.55%
Cap/Sales 0.2%
Interest Coverage 1.53
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC15.92%
ROIC/WACC0.19
Cap/Depr(3y)150.16%
Cap/Depr(5y)245.19%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.6%
EPS 3Y-12.51%
EPS 5Y-8.32%
EPS Q2Q%28.86%
EPS Next Y33.96%
EPS Next 2Y18.93%
EPS Next 3Y17.51%
EPS Next 5Y8.79%
Revenue 1Y (TTM)31.67%
Revenue growth 3Y6.3%
Revenue growth 5Y7.88%
Sales Q2Q%7.19%
Revenue Next Year4.63%
Revenue Next 2Y4.52%
Revenue Next 3Y7%
Revenue Next 5YN/A
EBIT growth 1Y84.63%
EBIT growth 3Y10.47%
EBIT growth 5Y7.74%
EBIT Next Year113.82%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-120.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.43%
OCF growth 3YN/A
OCF growth 5YN/A